SLC2A1 and Alzheimer disease: The number of glucose transporters is reduced in AD (Simpson et al., 1994; Mooradian et al., 1997), and accelerated amyloid load and aggravated Aβ accumulation recently were shown in a transgenic mouse model of AD with GLUT1 deficiency (Winkler et al., 2015).